Hims & Hers Health (HIMS) Competitors $49.41 +1.63 (+3.41%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, GH, RDNT, OPCH, BTSG, SHC, WGS, CON, PRVA, and SGRYShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Sotera Health (SHC), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Its Competitors Natera Guardant Health RadNet Option Care Health BrightSpring Health Services Sotera Health GeneDx Concentra Group Holdings Parent Privia Health Group Surgery Partners Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Does the media prefer NTRA or HIMS? In the previous week, Natera had 8 more articles in the media than Hims & Hers Health. MarketBeat recorded 33 mentions for Natera and 25 mentions for Hims & Hers Health. Natera's average media sentiment score of 1.34 beat Hims & Hers Health's score of 0.75 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 25 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 10 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B13.97-$190.43M-$1.91-90.45Hims & Hers Health$1.48B7.57$126.04M$0.8061.80 Which has more risk and volatility, NTRA or HIMS? Natera has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500. Do analysts recommend NTRA or HIMS? Natera presently has a consensus price target of $194.00, suggesting a potential upside of 12.29%. Hims & Hers Health has a consensus price target of $38.92, suggesting a potential downside of 21.29%. Given Natera's stronger consensus rating and higher probable upside, analysts clearly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-12.89% -22.22% -15.03% Hims & Hers Health 9.63%26.26%13.06% Do insiders and institutionals have more ownership in NTRA or HIMS? 99.9% of Natera shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.6% of Natera shares are held by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryNatera beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$11.23B$2.09B$5.80B$21.53BDividend YieldN/AN/A5.25%3.51%P/E Ratio62.1035.2475.8129.61Price / Sales7.5710.18536.5552.38Price / Cash135.7057.3337.4224.46Price / Book22.8911.5011.754.59Net Income$126.04M-$63.67M$3.29B$999.91M7 Day Performance2.40%0.68%1.57%1.04%1 Month Performance-1.04%6.42%8.46%6.38%1 Year Performance223.56%37.49%63.87%16.89% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health2.65 of 5 stars$50.38+5.4%$38.92-22.7%+229.5%$11.34B$1.48B62.731,637Gap UpNTRANatera3.1097 of 5 stars$167.88-0.1%$194.00+15.6%+43.0%$23.04B$1.70B-87.884,434Positive NewsInsider TradeGHGuardant Health4.1914 of 5 stars$59.77-0.6%$58.24-2.6%+119.2%$7.43B$739.02M-17.792,021Positive NewsRDNTRadNet3.8285 of 5 stars$71.90+0.7%$76.80+6.8%+18.2%$5.49B$1.83B-356.8111,021Positive NewsOPCHOption Care Health4.9528 of 5 stars$29.23+0.5%$35.75+22.3%-11.6%$4.76B$5.00B23.448,088News CoveragePositive NewsBTSGBrightSpring Health Services1.752 of 5 stars$25.44+5.4%$25.67+0.9%+106.9%$4.53B$11.27B82.4735,000Positive NewsAnalyst ForecastHigh Trading VolumeSHCSotera Health1.82 of 5 stars$15.86+1.5%$16.00+0.9%-2.4%$4.51B$1.10B198.293,000News CoverageInsider TradeHigh Trading VolumeWGSGeneDx2.2277 of 5 stars$129.79-2.1%$101.63-21.7%+265.9%$3.72B$305.45M2,593.061,200Positive NewsGap UpCONConcentra Group Holdings Parent3.0419 of 5 stars$23.07-0.1%$27.50+19.2%-5.3%$2.96B$1.90B19.3911,250Positive NewsPRVAPrivia Health Group4.2888 of 5 stars$23.41+0.6%$28.58+22.1%+22.4%$2.88B$1.90B213.181,140Positive NewsSGRYSurgery Partners3.1371 of 5 stars$22.12-1.8%$33.00+49.2%-27.9%$2.83B$3.11B-15.4615,000Positive NewsInsider Trade Related Companies and Tools Related Companies NTRA Competitors GH Competitors RDNT Competitors OPCH Competitors BTSG Competitors SHC Competitors WGS Competitors CON Competitors PRVA Competitors SGRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HIMS Stock Alerts